John Renger

Insider Reports History

Entity
Individual
Location
C/O Cerevel Therapeutics, Inc., 51 Ashtor Place, New York, NY
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Renger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by John Renger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 4 $0 4 Aug 5, 2024 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2024 3 -$89.8K 4 Feb 8, 2024 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Nov 1, 2022 5 -$561K 4 Nov 3, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Oct 4, 2022 5 -$561K 4 Oct 6, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Aug 10, 2022 6 -$1.86M 4 Aug 12, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Aug 5, 2022 6 -$923K 4 Aug 9, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Jul 20, 2022 3 -$663K 4 Jul 22, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Jul 5, 2022 6 -$695K 4 Jul 7, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Apr 13, 2022 3 -$1.4M 4 Apr 15, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Mar 29, 2022 3 -$315K 4 Mar 31, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Mar 16, 2022 6 -$1.24M 4 Mar 18, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Mar 9, 2022 4 -$895K 4 Mar 11, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Mar 2, 2022 3 -$663K 4 Mar 4, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 4 -$663K 4 Feb 11, 2022 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 23, 2021 6 -$315K 4 Dec 28, 2021 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 21, 2021 3 -$212K 4 Dec 23, 2021 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 15, 2021 9 -$1.03M 4 Dec 17, 2021 Chief Scientific Officer
CERE Cerevel Therapeutics Holdings, Inc. Nov 10, 2021 7 -$2M 4 Nov 15, 2021 Chief Scientific Officer